Source:http://linkedlifedata.com/resource/pubmed/id/11021613
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-10-19
|
pubmed:abstractText |
This Ontario province-wide cohort study was conducted to compare the risk of adverse pregnancy outcomes in female childhood cancer survivors who received abdominal-pelvic radiation and/or chemotherapy with alkylating agents with the risk among those who were treated by non-sterilizing alkylating agents with the risk among those who were treated by non-sterilizing surgery only. Females in Ontario, Canada, diagnosed in 1964-1988 before age 20 with a histologically confirmed malignancy and who had survived for at least 5 years, attained age 18, and were alive at the time of study, were identified through the Ontario Cancer Registry. We ascertained pregnancy outcomes by a telephone-administered questionnaire. Treatment data were abstracted from medical records for 830 subjects 18-49 years of age, the analysis comprised 340 survivors who had one or more pregnancies after treatment. There was no evidence of an increased risk of having a spontaneous abortion or an infant with a birth defect. Survivors receiving abdominal-pelvic radiation were more likely to have a low birth weight infant (odds ratio estimate [OR] = 3.64; 95% confidence interval [CI] = 1.33-9.96), a premature low birth weight infant (OR = 3.29; 95% CI = 0.97-11.1), or an infant who died in the perinatal period (OR = 2.41; 95% CI = 0.50-11.5), compared with those receiving surgery. Risks of perinatal death and having a low birth weight infant increased with dose of radiotherapy directed to the abdomen.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1044-3983
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11021613-Adult,
pubmed-meshheading:11021613-Antineoplastic Agents, Alkylating,
pubmed-meshheading:11021613-Cohort Studies,
pubmed-meshheading:11021613-Female,
pubmed-meshheading:11021613-Humans,
pubmed-meshheading:11021613-Infant, Low Birth Weight,
pubmed-meshheading:11021613-Infant, Newborn,
pubmed-meshheading:11021613-Logistic Models,
pubmed-meshheading:11021613-Neoplasms,
pubmed-meshheading:11021613-Ontario,
pubmed-meshheading:11021613-Pelvis,
pubmed-meshheading:11021613-Pregnancy,
pubmed-meshheading:11021613-Pregnancy Outcome,
pubmed-meshheading:11021613-Questionnaires,
pubmed-meshheading:11021613-Registries,
pubmed-meshheading:11021613-Retrospective Studies
|
pubmed:year |
2000
|
pubmed:articleTitle |
Pregnancy outcomes in females after treatment for childhood cancer.
|
pubmed:affiliation |
Division of Preventive Oncology, Cancer Care Ontario, University of Toronto, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|